Product: | Metformin-d6 hydrochloride | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D11574 | ||||||||||||
CAS Number: | 1185166-01-1 | ||||||||||||
Synonyms: |
N,N-Dimethylimidodicarbonimidic Diamide-d6 Hydrochloride; Diabetosan-d6; Diabex-d6; Glucophage-d6; Metiguanide-d6 |
||||||||||||
Pricing: |
|
||||||||||||
Formula: | C4H6D6ClN5 | ||||||||||||
Enrichment: | 99.96%D | ||||||||||||
Chemical Purity: | 99.6% | ||||||||||||
Molecular Weight: | 171.66 | ||||||||||||
Structure: | |||||||||||||
Category: | Labeled Reference Standards | ||||||||||||
Storage: | -20 deg. C | ||||||||||||
Transportation: | Non-hazardous for Transport | ||||||||||||
Literature References: |
Hundal RS, Inzucchi SE, Metformin: new understandings, new uses. Drugs, 2003, 63 (18): 1879–94.; El Messaoudi, S; Rongen, GA; de Boer, RA; Riksen, NP, The cardioprotective effects of metformin. Current Opinion in Lipidology, 2011, Dec., 22(6): 445–53.; Malek, M; Aghili, R; Emami, Z; Khamseh, ME, Risk of Cancer in Diabetes: The Effect of Metformin. ISRN Endocrinology, 2013, 2013: 636927-636936. |
||||||||||||
MSDS: | |||||||||||||
Applications: | A labeled Reference Standard for Metformin, an antidiabetic for Type 2 diabetes. Also used to treat polycystic ovary syndrome. Suppresses glucose production by the liver. May prevent cardiovascular and cancer complications of diabetes. Helps reduce LDL cholesterol and triglyceride levels. |